Clinical

Dataset Information

0

Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer


ABSTRACT: To estimate the progression free survival for subjects treated with panitumumab in combination with a chemotherapy regimen of oxaliplatin, 5-Fluorouracil (5-FU) and leucovorin (FOLFOX) as first-line chemotherapy regimen for subjects with metastatic colorectal cancer with WT (wild type) KRAS according to the IGFRp (protein receptor insulin growth factor) and MMP-7 (Matrilysin) expression.

DISEASE(S): Metastatic Colorectal Cancer,Pacientes Con Cáncer Colorrectal Metastásico Y Tumor Con Kras No Mutado Tratados Con Folfox6m Y Panitumumab Como Tratamiento De Primera Línea,Colorectal Neoplasms

PROVIDER: 2101702 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2011-10-21 | GSE24818 | GEO
| S-EPMC3417090 | biostudies-literature
| 2526396 | ecrin-mdr-crc
2011-10-20 | E-GEOD-24818 | biostudies-arrayexpress
2024-09-01 | GSE266913 | GEO
| S-EPMC2770569 | biostudies-literature
2020-01-13 | GSE111822 | GEO
| S-EPMC5440342 | biostudies-literature
| S-EPMC4800341 | biostudies-literature
2010-05-17 | GSE13070 | GEO